Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling

被引:0
|
作者
Pradip Shahi Thakuri
Megha Gupta
Sunil Singh
Ramila Joshi
Eric Glasgow
Alexander Lekan
Seema Agarwal
Gary D. Luker
Hossein Tavana
机构
[1] The University of Akron,Department of Biomedical Engineering
[2] The University of Akron,Department of Arts and Sciences
[3] Georgetown University Medical Center,Lombardi Cancer Center
[4] Georgetown University Medical Center,Department of Pathology, Center for Cell Reprogramming
[5] University of Michigan,Department of Radiology
[6] University of Michigan,Department of Microbiology and Immunology
[7] University of Michigan,Department of Biomedical Engineering
来源
BMC Cancer | / 20卷
关键词
Phytochemical; TNBC; Cell migration; Invasion; Metastasis; Protein kinases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase
    Seo, Juyeon
    Park, Minsu
    Ko, Dongmi
    Kim, Seongjae
    Park, Jung Min
    Park, Soeun
    Nam, Kee Dal
    Farrand, Lee
    Yang, Jinsol
    Seok, Chaok
    Jung, Eunsun
    Kim, Yoon-Jae
    Kim, Ji Young
    Seo, Jae Hong
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (05)
  • [22] Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF
    Yang, Kaihua
    Yao, Yufeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (09): : 5858 - 5868
  • [23] Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase
    Juyeon Seo
    Minsu Park
    Dongmi Ko
    Seongjae Kim
    Jung Min Park
    Soeun Park
    Kee Dal Nam
    Lee Farrand
    Jinsol Yang
    Chaok Seok
    Eunsun Jung
    Yoon-Jae Kim
    Ji Young Kim
    Jae Hong Seo
    Cellular and Molecular Life Sciences, 2023, 80
  • [24] Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
    Rigiracciolo, Damiano Cosimo
    Santolla, Maria Francesca
    Lappano, Rosamaria
    Vivacqua, Adele
    Cirillo, Francesca
    Galli, Giulia Raffaella
    Talia, Marianna
    Muglia, Lucia
    Pellegrino, Michele
    Nohata, Nijiro
    Di Martino, Maria Teresa
    Maggiolini, Marcello
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38
  • [25] Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells
    Zuhal Hamurcu
    Nesrin Delibaşı
    Seda Geçene
    Elif Funda Şener
    Hamiyet Dönmez-Altuntaş
    Yusuf Özkul
    Halit Canatan
    Bulent Ozpolat
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 415 - 430
  • [26] Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
    Bousquet, Guilhem
    El Bouchtaoui, Morad
    Sophie, Tan
    Leboeuf, Christophe
    de Bazelaire, Cedric
    Ratajczak, Philippe
    Giacchetti, Sylvie
    de Roquancourt, Anne
    Bertheau, Philippe
    Verneuil, Laurence
    Feugeas, Jean-Paul
    Espie, Marc
    Janin, Anne
    ONCOTARGET, 2017, 8 (21) : 35205 - 35221
  • [27] Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer
    Islam, Rajibul
    Yen, Khor Poh
    Rani, Nur Najihah Izzati Mat
    Hossain, Md. Selim
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 112
  • [28] Prospectives of mirna gene signaling pathway in triple-negative breast cancer
    Chakkaravarthi, Kamali
    Ramesh, Rajashree
    Palaniyandi, Thirunavukkarasu
    Baskar, Gomathy
    Viswanathan, Sandhiya
    Wahab, Mugip Rahaman Abdul
    Surendran, Hemapreethi
    Ravi, Maddaly
    Sivaji, Asha
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [29] CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
    Zhang, Lianmei
    Zhao, Yang
    Yang, Jing
    Zhu, Yaning
    Li, Ting
    Liu, Xiaoyan
    Zhang, Pengfei
    Cheng, Jingliang
    Sun, Suan
    Wei, Chunli
    Fu, Junjiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Editorial: Targeting triple negative breast cancer by natural compounds
    Kumar, Shashank
    Gupta, Sanjay
    Chandra Gupta, Subash
    FRONTIERS IN PHARMACOLOGY, 2023, 14